|Bid||0.00 x 800|
|Ask||0.00 x 900|
|Day's Range||14.01 - 14.57|
|52 Week Range||13.53 - 22.22|
|Beta (5Y Monthly)||1.09|
|PE Ratio (TTM)||8.79|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of falling...
If you're like me, your investment watch list is overflowing with dozens of stocks and price alerts. Let's examine three biotechs trading at lower than average valuations and consider whether they might be worth putting on your watch list. Supernus Pharmaceuticals (NASDAQ: SUPN) makes drugs that treat disorders of the central nervous system, including epilepsy and Parkinson's disease.
Ladies and gentlemen, thank you for standing by, and welcome to the Fourth Quarter and Full Year 2020 Coherus BioSciences Conference Call. Today's call includes forward-looking statements regarding Coherus' current expectations.